Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-24-079033
Filing Date
2024-07-10
Accepted
2024-07-10 21:10:22
Documents
2
Group Members
ADAR1 CAPITAL MANAGEMENT GP, LLCDANIEL SCHNEEBERGER

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2419166d1_sc13g.htm SC 13G 83499
2 EXHIBIT A tm2419166d1_ex99-a.htm EX-99.A 4390
  Complete submission text file 0001104659-24-079033.txt   89576
Mailing Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540 609-649-9272
Acasti Pharma Inc. (Subject) CIK: 0001444192 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: SC 13G | Act: 34 | File No.: 005-87760 | Film No.: 241110919
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3503 WILD CHERRY DRIVE BUILDING 9 AUSTIN TX 78738
Business Address 3503 WILD CHERRY DRIVE BUILDING 9 AUSTIN TX 78738 512-254-3790
ADAR1 Capital Management, LLC (Filed by) CIK: 0001940272 (see all company filings)

EIN.: 000000000 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13G